QSS
RARE icon

Quantitative Systematic Strategies’s Ultragenyx Pharmaceutical RARE Stock Holding History

Quantitative Systematic Strategies’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-2,704
Closed -$305K – 694
2015
Q4 		$305K Buy
+2,704
New +$270K 0.08% 504

Other funds holding RARE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Quantitative Systematic Strategies's RARE Position: Q1 2016 in Review

Quantitative Systematic Strategies sold out of Ultragenyx Pharmaceutical (RARE) in Q1 2016, closing a stake of 2,704 shares — an estimated $305K sold.

Quantitative Systematic Strategies first reported a position in RARE in Q4 2015 and held it in 1 quarter. The position peaked at $305K in Q4 2015. 161 funds tracked by Wall St. Rank hold RARE as of Q1 2016.

  • Quantitative Systematic Strategies reported no remaining Ultragenyx Pharmaceutical position as of Q1 2016 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 2,704 Ultragenyx Pharmaceutical shares in Q1 2016, an estimated $305K.
  • Quantitative Systematic Strategies first reported a position in Ultragenyx Pharmaceutical in Q4 2015 and held it in 1 quarter.
  • Quantitative Systematic Strategies's Ultragenyx Pharmaceutical position peaked at $305K in Q4 2015.
  • 161 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q1 2016.

Based on Quantitative Systematic Strategies's 13F filing for Q1 2016, filed 22 Apr 2016.